Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

US Health Providers Seek HHS To Defer Data Block For A Year

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Precision Diagnostics Accelerating Early Detection

The fundamental strategy of clinical medicine is shifting from managing symptoms to identifying the earliest molecular indicators of disease. By integrating sophisticated genomic analysis with high-fidelity imaging, practitioners are now able to intercept pathological processes long before they manifest as systemic illness, significantly improving the efficacy of therapeutic interventions.

UK Medical Device Testing Jumps 17%,...

Clinical investigations of medical devices in the UK reached...

Ten hospital and medical associations in the US have requested that the information blocking deadline of October 6 be extended by one year to Secretary Xavier Becerra of Health and Human Services. The organisations wrote to Becerra on September 26th that despite the best efforts to educate their members, there are still major knowledge gaps and confusion within the provider and vendor sectors with regard to the administration and enforcement of information blocking legislation.

The associations also want HHS to notify doctors and providers of corrective actions before enacting any financial penalties or starting a formal investigation.

According to regulations set by the Office of the National Coordinator for Health Information Technology as well as the Centers for Medicare and Medicaid Services, stakeholders are required to begin sharing electronic health information on October 6. Information blocking tactics were outlawed by the ONC Final Rule for providers, health IT developers, health information exchanges, and health information networks.

It included specifications for the use of Fast Healthcare Interoperability Resources (FHIR) and Application Programming Interfaces (API) capabilities. Later, the regulation was broadened to call for information exchange with eight exceptions.

The organisations stated that their members have been working hard to fulfil the imminent and impending information blocking deadline of October 6th with the extended electronic health information (EHI) definition. The pervasive inability to support access, sharing, and use of electronic health information, according to the groups, is a major problem affecting compliance readiness. They said that EHI is not well defined and that there is no technical platform that supports its secure exchange.

Additionally, each healthcare stakeholder has a very different understanding of what constitutes electronic protected health information, a data repository service, and electronic health information. They stated that consistency in EHI interpretation is essential because the organisations are responsible for EHI interoperability.

Furthermore, there is still a lot of ambiguity regarding how the eight information blocking instances should be used while exchanging EHI, they added. When test results and reports are made public in cases of life-threatening or life-limiting illnesses, there are worries about the harm that may result. Additionally, there aren’t enough technical and regulatory manuals to support healthcare professionals in safeguarding private health information, such as reproductive, mental health, and substance use disorder data for adolescents and adults.

They stated that they continue to evaluate and monitor ONC’s frequently asked questions, but many of the questions that are raised are not satisfactorily addressed. In the letter, the provider organisations expressed their appreciation for HHS’s ongoing efforts to expand health data transfer and interoperability while progressing health equity for all, but noted that it was clear that vendors as well as healthcare providers, clinicians, and other professionals were not completely ready for the October 6 deadline.

The interoperability and information-blocking requirements of the 21st Century Cures Act were to be fulfilled by the ONC and CMS regulations.

Patients now have online access to their protected health information according to the CMS Interoperability and Patient Access Rule, which was published in 2020. In order for patients to readily obtain their claims and encounter information, comprising cost, as well as personal clinical information through third-party apps of their choice, it was necessary for payers to establish and sustain a secure, standards-based HL7 FHIR API. Payers also had to use a standards-based API to make provider directory data accessible to the general public.

Latest stories

Related stories

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Precision Diagnostics Accelerating Early Detection

The fundamental strategy of clinical medicine is shifting from managing symptoms to identifying the earliest molecular indicators of disease. By integrating sophisticated genomic analysis with high-fidelity imaging, practitioners are now able to intercept pathological processes long before they manifest as systemic illness, significantly improving the efficacy of therapeutic interventions.

UK Medical Device Testing Jumps 17%, AI and Neurotech Lead

Clinical investigations of medical devices in the UK reached...

Medtronic Secures FDA PMA for Infuse Bone Graft in TLIF

Medtronic announced that it has secured FDA premarket approval...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »